- •Foreword
- •Preface
- •Contents
- •Contributors
- •Chapter 1
- •1.1 Introduction
- •1.2 Limitations of Time-Domain OCT
- •1.4 Conclusion
- •References
- •Chapter 2
- •2.1 Background
- •2.3 Clinical Application
- •2.4 Conclusions
- •References
- •Chapter 3
- •Fluorescein Angiography
- •3.1 Principles of Fluorescein Angiography
- •3.2 Procedures for Fluorescein Angiography
- •3.4 Time Course of Fluorescein Angiography
- •3.5 Interpretation of Fluorescein Angiography
- •3.5.1 Hypofluorescent Lesions
- •3.5.2 Hyperfluorescent Lesions
- •3.6 Fluorescein Angiography Today
- •References
- •Chapter 4
- •Wide-Field Imaging and Angiography
- •4.1 Introduction
- •4.2 History of Fundus Imaging
- •4.3.1 Fluorescein Angiography with a Scanning Laser Ophthalmoscope
- •4.3.2 Advantages of Imaging with a Scanning Laser Ophthalmoscope
- •4.4 Clinical Use of Wide-Field Imaging
- •4.4.1 Wide-Field Imaging in Uveitis
- •4.4.4 Wide-Field Imaging of Choroidal Tumors
- •4.5 Future Directions for Fundus Imaging
- •4.6 Conclusion
- •References
- •Chapter 5
- •Autofluorescence Imaging
- •5.1 Introduction
- •5.2 What is Fundus Autofluorescence?
- •5.3 Identification of Early Disease Stages
- •5.4 Phenotyping
- •5.5 Disease Markers
- •5.6 Monitoring of Disease Progression
- •5.7 Disease Mapping
- •5.8 Functional Correlation
- •References
- •Chapter 6
- •Imaging the Macular Pigment
- •6.1 Macular Pigment
- •6.1.1 Characteristics and Potential Functions
- •6.1.3 Spatial Distribution
- •6.1.4 Modifying the Macular Pigment
- •6.1.5 MPOD and Age
- •6.2 Measurement Techniques
- •6.2.1 Heterochromatic Flickerphotometry
- •6.2.2 Fundus reflectance
- •6.2.3 Autofluorescence
- •6.2.4 Raman spectroscopy
- •6.2.5 How do different techniques compare
- •6.3 Imaging
- •6.3.1 Heterochromatic Flickerphotometry
- •6.3.2 Fundus Reflectance
- •6.3.3 Autofluorescence
- •6.3.4 Raman spectroscopy
- •References
- •Chapter 7
- •7.1 Introduction
- •7.2 Origin of Near-Infrared Autofluorescence
- •7.3 RPE Melanin: Role and Aging
- •7.4 Clinical Cases
- •7.4.1 Age-Related Macular Degeneration
- •7.4.2 Retinal Dystrophies
- •7.4.2.1 Stargardt’s Disease
- •7.4.2.2 Best’s Disease
- •7.4.2.3 Retinitis Pigmentosa
- •7.5 Conclusion
- •References
- •Chapter 8
- •8.1 Introduction
- •8.3.1.1 Classic Choroidal Neovascularization
- •8.3.1.2 Occult Choroidal Neovascularization
- •8.3.1.4 Mixed-Type Choroidal Neovascularization
- •8.3.1.5 Retinal Angiomatous Proliferation
- •8.3.3 Fibrovascular Scar
- •8.5 Conclusions
- •References
- •Chapter 9
- •9.1 Fundus Cameras
- •9.1.1 Standard Images
- •9.1.2 Wide-Angle Images
- •9.1.2.1 Pomerantzeff Equator Plus
- •9.1.2.2 RetCam™
- •RetCam™ Camera Description
- •RetCam™ Technique of Image Capture
- •RetCam™ Problems
- •9.1.2.3 Panoret™
- •9.1.2.4 Optos™
- •9.2.1 Retinal Tumors
- •9.2.1.1 Retinoblastoma
- •9.2.1.2 Astrocytic Hamartoma
- •9.2.1.4 Retinal Cavernous Hemangioma
- •9.2.1.5 Retinal Racemose Hemangioma
- •9.2.1.6 Vasoproliferative Tumor
- •9.2.2 Retinal Pigment Epithelium Tumors
- •9.2.3 Choroidal Tumors
- •9.2.3.1 Choroidal Nevus
- •9.2.3.2 Choroidal Melanoma
- •9.2.4 Anterior Segment Lesions
- •9.2.4.1 Iris Lesions
- •References
- •Chapter 10
- •Metabolic Mapping
- •10.1 Aspects of Metabolism
- •10.4.1 Technical Solution
- •10.5 Clinical Results
- •10.5.1 Age-Related Macular Degeneration
- •10.5.1.1 Detection of Alterations in Early AMD
- •10.5.1.2 Lifetime Images in Late AMD
- •Non-Exudative AMD and Geographic Atrophy
- •Exudative AMD
- •10.5.2.1 Arterial Branch Occlusion
- •10.5.3 Metabolic Alteration in Diabetes Mellitus
- •10.5.3.1 Detection of Fields of Reduced Metabolism
- •References
- •Chapter 11
- •11.1 Diabetic Macular Edema
- •11.2 Examinations in Diabetic Macular Edema
- •11.3 Treatment of Diabetic Macular Edema
- •References
- •Chapter 12
- •12.1.1 Incidence and Natural History
- •12.2 Investigation of Diagnostic Accuracy of OCT for Detection of DME
- •12.2.2 Diagnostic Accuracy of OCT for Detection of DME: Are Photography or Biomicroscopy a Valid Gold Standard?
- •12.2.3 Diagnostic Accuracy of OCT to Detect CSME Using Time-Domain OCTs: How to Use OCT Retinal Thickness Cut-Offs?
- •12.3 Use of OCT When Compared with Photography: Beyond Diagnostic Accuracy
- •12.4 Appendix: Reproducibility of OCT Retinal-Thickness Measurement in Patients with DME
- •12.4.1 How Reproducibility is Reported
- •12.4.3 Spectral-Domain OCTs Reproducibility
- •References
- •Chapter 13
- •13.2 Clinical Features
- •13.3 Examination
- •13.4 Natural History
- •13.5 Ultra-High Resolution OCT and Spectral OCT Findings in Macular Holes
- •13.6 Macular Hole Formation
- •13.7 Postoperative Appearance
- •13.8 Theory of Macular Hole Closure After Vitrectomy
- •13.9 Surgical Considerations
- •13.11 Clinical Features
- •13.12 Treatment
- •References
- •Chapter 14
- •14.1 Introduction
- •14.2 Vitreous Biochemistry
- •14.3 Vitreo-Retinal Interface Anatomy
- •14.4 Anomalous Posterior Vitreous Detachment (PVD)
- •14.5 Spectral-Domain OCT (SD-OCT)
- •14.6 Vitreo-Maculopathies
- •14.6.1 Macular Pucker (MP)
- •14.6.2 Macular Hole (MH)
- •14.6.2.1 Lamellar Hole (LH)
- •14.6.3 Age-Related Macular Degeneration (AMD)
- •14.6.4 Vitreo-Macular Traction Syndrome (VMTS)
- •14.7 Conclusion
- •References
- •Chapter 15
- •15.3 Imaging the Choroid
- •15.4 Age-Related Choroidal Atrophy
- •15.5 Choroid in High Myopia
- •15.8 Volume Rendering
- •15.9 Summary
- •References
- •Chapter 16
- •16.1 Introduction
- •16.2 Optical Coherence Tomography
- •16.3 Role of Optical Coherence Tomography
- •References
- •Chapter 17
- •17.1 Background and Motivation
- •17.2 Three-Dimensional Imaging of the Choroid
- •17.3 In Vivo Cellular Resolution Retinal Imaging
- •17.4 Polarization Sensitive Retinal OCT
- •17.5 Doppler (Blood Flow) Retinal OCT
- •References
- •Chapter 18
- •Toward Molecular Imaging
- •Summaries for the Clinician
- •References
- •Index
122 10 Metabolic Mapping
ocular lens was implanted into his eye. As shown in Fig. 10.13a and c, both the amplitude a1 in the shortwavelength channel and the fluorescence intensity as the sum of all detected photons are reduced at the coagula-
10 tion spots. That is, the fluorescence of RPE is eliminated, emitting with a short lifetime. In contrast, the long lifetimes of connective tissue are detectable at the coagulation spots (Fig. 10.13b). The force of each laser spot can be evaluated according to the detectable lifetime.
Measurements of dynamic fluorescence open the way for objective estimation of laser therapy in diabetes. As the lifetime t2 in the range of 1,000–1,500 ps in the shortwavelength channel is characteristic of unsupplied retinal tissue, its contribution should be reduced after laser coagulation.
Summary for Clinicians
■Time-resolved measurement of endogenous fluorophores in different spectral ranges in combination with selected spectral excitation is a new method for the investigation of cellular metabolism.
■The origination of pathological changes can be determined in a reversible state.
■Individual adapted therapy might be possible on the basis of lifetime measurements.
■Measurement of lifetime is suited to therapy control.
References
1. Schweitzer D, Leistritz L, Hammer M et al (1995) Calibration-free measurement of the oxygen saturation in retinal vessels of men. Ophthalmic Technol V, SPIE 2393: 210–218
2. Feke GT (2006) Laser Doppler instrumentation for the measurement of retinal blood flow: theory and practice. Bull Soc Belge Ophtalmol 302:171–184
3. Leitgeb RA, Schmetterer L, Hitzenberger CK et al (2004) Real-time measurement of in vitro flow by Fourier-domain color Doppler optical coherence tomography. Opt Lett 29(2):171–173
4. Beach JM, Schwenzer KJ, Srinivas S et al (1999) Oximetry of retinal vessels by dual-wavelength imaging: calibration and influence of pigmentation. J Appl Physiol 86(2): 748–758
5. Schweitzer D, Hammer M, Kraft J et al (1999) In vivo measurement of the oxygen saturation of retinal vessels in healthy volunteers. IEEE Trans Biomed Eng 46 (12): 1454–1465
6. Schweitzer D, Lasch A, van der Vorst S et al (2007) Änderung der retinalen Sauerstoffsättigung bei Gesunden
und in frühen Stadien der diabetische Retinopathie nach Atmung von 100% Sauerstoff. Klin Monatsbl Augenheilkd 224:402–410
7. Stryer L (1991) Biochemie. Spectrum Akademischer, Verlag GmbH Heidelberg
8. Boettner EA, Wolter JR (1962) Transmission of the ocular media. Invest Ophthalmol 1:776–783
9. La Schiazza O, Bille JF (2008) High-speed two-photon excited autofluorescence imaging of ex vivo human retinal pigment epithelial cells toward age-related macular degen-
eration diagnostic. J Biomed Opt 13(6):064008
10.American National Standard for the safe use of laser ANSI Z 136.1–2000 (2000) Laser Institute of America, Orlando, FL
11.Schweitzer D, Schenke S, Hammer M et al (2007) Towards metabolic mapping of the human retina. Microsc Res Tech 70:410–419
12.Sionkowska A, Skopinska J, Wisniewski M et al (2007) Spectroscopic studies into the influence of UV radiation on elastin in the presence of collagen. J Photochem Photobiol B Biol 86:186–191
13.Skala MC, Riching KM, Gendron-Fitzpatrick A et al (2007) In vivo multiphoton microscopy of metabolic oxidationreduction states and fluorescence lifetimes in normal and pre-cancerous epithelia. Proc Natl Acad Sci U S A 104(49): 19494–19499
14.Yagi K, Tanaka F, Nakashima N et al (1983) Picosecond laser fluorometry of FAD of D-amino acid oxidasebenzoate complex. J Biol Chem 258(6):3799–3802
15.Nakashima N, Yoshihara K, Tanaka F et al (1980) Picosecond fluorescence lifetime of the coenzyme of D-amino acid oxidase. J Biol Chem 255 (11):5261–5263
16.König K, Riemann I (2003) High-resolution multiphoton tomography of human skin with subcellular spatial resolution and picosecond time resolution. J Biomed Opt 8 (3): 432–439
17.Schneckenburger H, Wagner M, Weber P et al (2004) Autofluorescence lifetime imaging of cultivated cells using a UV picosecond laser diode. J Fluoresc 14 (5): 649–654
18.Wu Y, Zheng W, Qu J (2006) Sensing cell metabolism by time-resolved autofluorescence. Opt Lett 31(21): 3122–3124
19.Schweitzer D, Jentsch S, Schenke S et al (2007) Spectral and time-resolved studies on ocular structures. In: Schweitzer D, Fitzmaurice M (eds) Diagnostic optical spectroscopy in biomedicine IV. Proceedings of the SPIE, 6628,pp 662807- 1–662807-12
20.Schweitzer D, Kolb A, Hammer M et al (2000) Tau mapping of the autofluorescence of the human ocular fundus. SPIE 4164:79–89
21.Goldenberg-Cohen N, Dadon S, Avraham BCR et al (2008) Molecular and histological changes following central retinal artery occlusion in a mouse model. Exp Eye Res 87: 327–333
22.Lakowicz JR (2007) Principles of fluorescence spectroscopy, 3rd edn. Kluwer, Academic, Plenum, New York
23.Becker W (2005) Advanced time-correlated single photon counting techniques. Springer Series in Chemical Physics 81. Springer, Berlin
24.Schweitzer D, Hammer M, Schweitzer F et al (2004) In vivo measurement of time-resolved autofluorescence at the human fundus. J Biomed Opt 9(6)1214–1222
25.Schweitzer D, Quick S, Schenke S et al (2009) Vergleich von Parametern der zeitaufgelösten Autofluoreszenz bei Gesunden und Patienten mit früher AMD. Ophthalmologe 9(6):714–722
26.AREDS Research Group (2001) A randomized, placebocontrolled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No 8. Arch Ophthalmol 119(10):1417–1436
27.Eldred GE, Katz ML (1988) Fluorophores of the human pigment epithelium: separation and spectral characterization. Exp Eye Res 47:71–86
28.Schweitzer D (2010) Quantifying fundus autofluorescence. In: Lois N, Forrester JV (eds) Fundus autofluorescence. Lippincott Williams & Wilkins, Philadelphia
References 123
29.Bindewald A, Bird AC, Dandekar SS et al (2005) Classification of fundus autofluorescence patterns in early age-related macular diseases. Invest Ophthalmol Vis Sci 46:3309–3314
30.Birol G, Budzynski E, Wangsa-Wirawan ND et al (2005) Retinal arterial occlusion leads to acidosis in the cat. Exp Eye Res 80:527–533
31.Wakita M, Nishimura G, Tamura M (1995) Some characteristics of the fluorescence lifetime of reduced pyridine nucleotides in isolated mitochondria, isolated hepatocytes, and perfused rat liver in situ. J Biochem 118:1151–1160
32.WangHW,GukassyanV,ChenCTetal(2008)Differentiation of apoptosis from necrosis by dynamic changes of reduced nicotinamide adenine dinucleotide fluorescence lifetime in live cells. J Biomed Opt 13(5):054011
